CARE Ratings Earnings Call: Key Takeaways
CARE Ratings delivered strong FY26 performance with consolidated revenue growth of 18% and PAT growth of 24%. Strategy focuses on scaling global ratings and AI-embedded analytics.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
38 announcements with these filters
CARE Ratings delivered strong FY26 performance with consolidated revenue growth of 18% and PAT growth of 24%. Strategy focuses on scaling global ratings and AI-embedded analytics.
CARE Ratings reported record financial performance in FY26, driven by a 16.1% surge in bank credit offtake and the successful turnaround of its non-ratings subsidiaries to profitability.
CARE Ratings delivered strong FY26 performance with consolidated revenue growing 18% to ₹473cr and PAT up 24% to ₹174cr. The company is pivoting towards AI-driven analytics and expanding its global rating footprint.
CARE Ratings recommended a final dividend of ₹14 per equity share. The record date is June 26, 2026, with payment scheduled by August 1, 2026.
CARE Ratings re-appointed B S R & Co. LLP as Statutory Auditors for five years. The decision ensures audit continuity following board approval.
CARE Ratings reported FY26 consolidated revenue of ₹473.07 Crore, up 18% year-on-year. The Board also recommended a final dividend of ₹14 per share.
CARE Ratings Ltd reported revenue from operations of ₹130.7 Cr (+19.1% YoY) and net profit of ₹53.4 Cr (+23.0% YoY) for Q4 FY26.
CARE Ratings approved FY26 audited financial results and recommended a ₹14 per share final dividend. It also approved a five-year statutory auditor re-appointment.